The women in groups at high risk for developing breast cancer are often given University of medications that reduce a particular genome of the cancer, but increase their risk of breast cancer and blood clots after other researchers in Oregon Health & Science. Their findings were published in the September-15. Issue of the Annals of Internal Medicine.
"We found that the three drugs that actually the risk of invasive breastCancer> 30-68%, "Dr. Heidi D. Nelson is a research professor at the University said.
These three drugs containing tamoxifen, raloxifene and tibolone. The researchers warned, however, that these drugs also had potentially dangerous side effects.
Daily walking has been shown to be more effective in reducing the risk of breast cancer without dangerous side effects in numerous studies. After 20 years in the Nurses' Health Study of 72,000 women, Walked for three hours a week, only 30 minutes per day of nursing cancer associated with a reduced risk of conducting a heavy burden.
Another study published in the New England Journal of Medicine focused on 26,000 women and found similar results with the risk of breast cancer decreases by 72%.
Tamoxifen has been found to reduce the risk of ER-positive breast cancer when the increased risk of developing ER-negative tumors (anotheraggressive form of cancer) of cancer survivors. More alarming tamoxifen and raloxifene blood clots is increased by 60-90%.
Walk every day, because the work allowed by a treadmill desk, several studies have demonstrated a high risk of contracting this type of cancer, of course, but also reduces the risk of blood clots at the same time.
No comments:
Post a Comment